

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.363, 2002-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


UK NICE issues guidance on infliximab in Crohn's disease
Inpharma, Vol. 1, Iss. 1338, 2002-01 ,pp. :


Infliximab worth it for Crohn's disease in the UK
Inpharma, Vol. 1, Iss. 1515, 2005-01 ,pp. :


By Blackmore Laura Harris Adam
Clinical Medicine, Vol. 12, Iss. 3, 2012-06 ,pp. :


UK NICE issues guidance on temozolomide for brain cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 311, 2001-01 ,pp. :


UK NICE issues guidance on temozolomide for brain cancer
Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. :